ARTICLE | Company News
VIB grants Oncurious rights to five preclinical oncology assets
October 20, 2017 12:29 AM UTC
In September, the Flanders Institute for Biotechnology (VIB) (Ghent, Belgium) granted Oncurious N.V. (Leuven, Belgium) exclusive rights to a portfolio of five undisclosed immuno-oncology assets in exchange for an additional stake in Oncurious. The institute now holds 15% of the biotech...